Absorption and metabolism of milk thistle flavanolignans in humans
- 1 December 2012
- journal article
- clinical trial
- Published by Elsevier in Phytomedicine
- Vol. 20 (1) , 40-46
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Bioavailability of dietary flavonoids and phenolic compoundsMolecular Aspects of Medicine, 2010
- Bioavailability and catabolism of green tea flavan-3-ols in humansNutrition, 2010
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis CThe Journal of Clinical Pharmacology, 2010
- Dietary phenolics: chemistry, bioavailability and effects on healthNatural Product Reports, 2009
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin TherapyGastroenterology, 2008
- Quantitation of Silibinin, a Putative Cancer Chemopreventive Agent Derived from Milk Thistle (Silybum marianum), in Human Plasma by High-Performance Liquid Chromatography and Identification of Possible MetabolitesJournal of Agricultural and Food Chemistry, 2007
- Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic ConsequencesClinical Cancer Research, 2006
- Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individualsThe Journal of Nutritional Biochemistry, 2005
- Milk thistle for the treatment of liver diseaseThe American Journal of Medicine, 2002
- Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liverJournal of Hepatology, 1989